It’s common for new presidents to withdraw pending rules before they’re published in the Federal Register, review them and then decide whether to re-issue them. But when it comes to health-care fraud, this might not be the best idea, and could harm anti-fraud efforts, sources told me. The Trump administration Jan. 27 withdrew a final rule that would have strengthened provider enrollment in Medicare and Medicaid.
The final rule would have required providers to disclose any affiliations with physicians who had been excluded or had their payments suspended by Medicare or Medicaid, among other provisions. Currently excluded providers can find ways to continue making money from Medicare by using a front person to start a new company or affiliating with someone who's able to bill Medicare, Louis Saccoccio, the chief executive officer of the National Health Care Anti-Fraud Association, told me.
The rule would have blocked these arrangements, Saccoccio said, as well as arrangements in which providers refused to repay debts to Medicare or Medicaid but still profited from the program through relationships with doctors who had billing privileges.
While it’s possible the final rule will be released at a later date, that likelihood decreased after President Trump signed an executive order intended to limit regulations, Linda Baumann, an attorney with Arent Fox, told me. The so-called “two-for-one” order requires agencies to eliminate two existing regulations for every new regulation they issue.
Baumann said she anticipated the Trump administration wouldn't resubmit the final rule in the near future because of its projected cost, as well as the need to repeal two existing regulations upon resubmission. The proposed rule is slated to cost $298.8 million per year for the first three years of implementation, which is a lot of money to offset through the elimination of existing regulations, she said.
Read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)